Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01922440 · ClinicalTrials.gov registry record

A Registry for Participants With Chronic Hypoparathyroidism

A clinical trial of Hypoparathyroidism, sponsored by Takeda.

Active
Registry status
1,339
Enrollment target
20
Study locations

NCT01922440 is a study of Hypoparathyroidism that is active but no longer recruiting, run by Takeda. The registered enrollment target is 1,339 participants, above the 66-participant average among 10 other Hypoparathyroidism trials with a reported enrollment target (1929% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01922440, a study of Hypoparathyroidism, is active but no longer recruiting, sponsored by Takeda.

ACTIVE NOT RECRUITING
Registry status
1,339 participants
Enrollment target
20
Study locations

Study Summary

The main aim of this study is to find out the long-term safety and effectiveness profile of recombinant human parathyroid hormone (1-84) (rhPTH\[1-84\]) treatment in participants with chronic hypoparathyroidism under conditions of routine clinical practice. Participants will be treated according to their clinic's standard practice determined by the treating doctors. Each participant will fill out a study questionnaire during a routine doctor visit.

Conditions Studied

Hypoparathyroidism

Interventions

  • OTHER No intervention

Study Locations (20)

Illinois

  • Suburban Endocrinology & Diabetes - Arlington Heights
  • University of Chicago Medical Center - Chicago
  • Northshore University Health System - Evanston
  • Loyola University Medical Center - Maywood

California

  • Children's Hospital Los Angeles - Los Angeles
  • Cedars-Sinai Medical Center - Los Angeles
  • Dr. Joselito Cabaccan - San Jose

Florida

  • Hanson Clinical Research Center - Port Charlotte
  • Thyroid & Endocrine Center of Florida - Sarasota

Maryland

  • Model Clinical Research - Baltimore
  • Medstar Union Memorial Hospital - Baltimore

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

Alabama

  • University of Alabama at Birmingham - Birmingham

Arizona

  • University of Arizona Medical Center - Tucson

Colorado

  • University of Colorado Hospital - Aurora

Trial Details

FieldValue
Enrollment Target 1,339 participants
Start Date 2013-07-30
Est. Completion 2034-11-30

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01922440

The ClinicalTrials.gov registry entry for NCT01922440 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,339 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 66-participant average among 10 other Hypoparathyroidism trials with a reported enrollment target (1929% higher). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoparathyroidism appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT01922440 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Illinois, California, Florida.

Frequently Asked Questions

What is clinical trial NCT01922440 about?

NCT01922440 is a clinical study titled "A Registry for Participants With Chronic Hypoparathyroidism". The main aim of this study is to find out the long-term safety and effectiveness profile of recombinant human parathyroid hormone (1-84) (rhPTH\[1-84\]) treatment in participants with chronic hypoparathyroidism under conditions of routine clinical practice. Participants will be treated according to...

What is the current status of trial NCT01922440?

This trial is currently active not recruiting. The enrollment target is 1,339 participants. The study started on 2013-07-30. Estimated completion is 2034-11-30.

What conditions does trial NCT01922440 study?

This clinical trial studies the following conditions: Hypoparathyroidism.

What interventions are being tested in trial NCT01922440?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT01922440?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01922440 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypoparathyroidism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypoparathyroidism

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.